Technology Transfer Session
Joseph M. Conrad III, J.D., Ph.D.
Senior Technology Transfer Manager
Invention Development & Marketing Unit
NCI, Technology Transfer Center
Dr. Conrad received his J.D. from George Washington University Washington College of Law; his Ph.D. in Biochemistry from American University; and his B.S. from Xavier University in New Orleans. He’s a former USPTO Patent Examiner and spent 5 years with two DC law firms before joining the NIH. While at the NIH, he worked at the National Institute of Allergy and Infectious Diseases’ (NIAID’s) Office of Technology Development (OTD), overseeing their invention docket and patent portfolio; and then moved to the National Cancer Institute’s (NCI), Technology Transfer Center (TTC), where he drafted and negotiated the transactional agreements that move technology from the labs into the private sector. More recently he transitioned to TTC’s newly created Invention Development & Marketing Unit (IDMU), where he focuses on invention marketing and outreach to stakeholders who are not aware that NIH/NCI technologies are available for licensing and co-development opportunities to enhance and grow companies’ product lines and commercial potential.
Haiqing Li, M.D., Ph.D.
Senior Technology Transfer and Patent Specialist
Technology Transfer and Intellectual Property Office
National Institute of Allergy and Infectious Diseases
National Institutes of Health
Dr. Li received her M.D. from Beijing University; and her Ph.D. in Cell Biology and Genetics, from Cornell University. After graduate school, Dr. Li joined NCI as a cancer research fellow, where she analyzed pharmacokinetic profiles and characterized biomarkers for novel cancer therapeutic reagents. She became a technology transfer fellow at NCI Technology Transfer Center (TTC) in 2007 and a full-time employee in 2009, where she negotiated agreements, reviewed invention reports and managed a patent portfolio. She joined NIAID Technology Transfer and Intellectual Property Office (TTIPO) as a senior specialist in 2012, supporting TTIPO Director and Deputy Director directly. For examples, she collects metrics and reports on NIAID technology transfer activities; she leads or participates in NIAID or NIH technology transfer projects such as TTIPO’s advancing development and commercialization initiative (ADCI).
Ajoy K. Prabhu, MS, MBA
Chief, Marketing Unit
NIH, Office of Technology Transfer
Ajoy Prabhu manages world-wide marketing of NIH and CDC developed technologies with a view towards having them licensed by the private sector and developed into drugs, vaccines and other biomedical products for the betterment of the public. Ajoy has twenty years’ experience in biotechnology, particularly the FDA regulated in-vitro diagnostics industry, clinical trials and scale-up manufacturing. Before joining NIH, he was VP, Business Development at a small biotech company where he conducted clinical trials and transferred technologies to Cote d’Ivore, Cameroon, Japan, China, India and The Philippines. Prior to that, he was a systems scientist at a large biotech company and developed robotic software and immunochemistry for diagnosing pregnancy, anemia, endocrine functions and tuberculosis. Ajoy has founded three companies in the U.S., Australia and India. He has a B.Sc. in Microbiology and a post-graduate degree in Clinical Analysis from Bombay University, an M.S. in Pathology and an M.B.A. from the University of Maryland. He has also authored several scientific papers and patents.
Senior Licensing & Patenting Manager
National Heart Lung & Blood Institute
Michael (Misha) Shmilovich has been with the NIH Technology Transfer program since February of 2003. Since Joining the office, he negotiated 379 to licenses, 146 of which were patent commercial licenses and 72 of which were exclusive licenses. Misha also served on various committees in charge of governing policy for NIH’s Technology Transfer program. Misha has a JD from American University Washington College of Law (bar membership USPTO, DC and California), a BS in molecular biology and genetics from the University of Michigan, Ann Arbor, graduate level course work including biotech track certifications from FAES in immunology and continues to take refresher and educational courses a FAES in life sciences and biotechnology with a particular focus on immunology. Misha guest lectured several of the TT FAES courses in the subject areas of contract law, patent law and federal technology transfer. Misha was guest speaker on tech transfer related topics at FLC, AUTM, Cleveland intellectual Property Association, Enterprise Ireland, Council of Scientific & Industrial Research (India) meetings.
Non-dilutive Funding and Resources for startups from the NIH SBIR/STTR Programs
Ashim Subedee, PhD
NCI SBIR Development Center
Dr. Ashim Subedee is a Program Director at the National Cancer Institute’s Small Business Innovation Research (SBIR) Development Center. Ashim manages SBIR & STTR grants and contracts with a focus on cancer therapeutics, prevention and med-tech including diagnostics and digital health. He provides oversight throughout the award period and mentors small business applicants and awardees in developing their technology goals and commercialization strategy. Additionally, he plays an active role in several center initiatives, including investor initiatives, translational resources and other workshops, and targeted funding opportunities. Prior to joining the SBIR Development Center, Ashim was a Presidential Management Fellow at the NIH and did rotations at multiple offices within the NIH and the FDA Center for Drug Evaluation and Research (CDER). Ashim received his PhD in Biological and Biomedical Sciences from Harvard University where his dissertation work was focused on molecular mechanisms of triple negative breast cancer.
Adam Sorkin (NIAID)
Adam M. Sorkin, MEM, MSE, PE is the NIAID Entrepreneur-in-Residence and Small Business Development Specialist. He supports most aspects of the NIAID’s Small Business Program, with a focus on commercialization and entrepreneurial assistance activities. He has over 15 years’ experience in biotechnology R&D and has helped raise over $50 Million in non-dilutive and dilutive funding for small businesses and start-ups. In 2015, Adam was the first Entrepreneur-in-Residence appointed at NIAID. Prior to joining NIH, he was an independent consultant, providing business development and research planning services to clients in biotechnology and healthcare industries. Previously, he served in multiple management and R&D roles at Arteriocyte, Inc. [now Compass Biomedical] and Arteriocyte Medical Systems, Inc. [now ISTO Biologics], overseeing multiple Military and Federally funded research to develop and test new technologies for drug delivery, vaccine research, and wound healing. Prior to that, he worked in extensively in the Cleveland Biotechnology community. Mr. Sorkin holds graduate degrees in Biomedical Engineering and Biotechnology Entrepreneurship from Tulane University and Case Western Reserve University and has been a licensed Professional Engineer for 15 years.
Lyndon Joseph, Ph.D
Health Scientist Administrator
Division of Geriatrics and Clinical Gerontology
National Institute on Aging, NIH, DHHS
Lyndon Joseph, Ph.D, an Exercise Physiologist, is a Program Officer at the National Institute on Aging’s Division of Geriatrics and Clinical Gerontology. His programmatic and research portfolio covers basic, translational and clinical studies related to musculoskeletal conditions, gait/balance, physical function, the effects of exercise and other interventions on chronic diseases and disability, disability trajectory and prevention, physical therapy and rehabilitation, falls and fall prevention, frailty, obesity, and physical activity/sedentary behavior in older adults. Before joining the NIA team, Dr. Joseph was an Assistant Professor in the Division of Gerontology, Department of Medicine at the University of Maryland Baltimore with a joint Research Fellow appointment in the Geriatric Research, Education and Clinical Center (GRECC) at The Baltimore Veterans Affairs Medical Center. His research focused on the effects of exercise and weight loss on metabolic abnormalities that are usually associated with aging such as diabetes, hypertension and dyslipidemia. Dr. Joseph received his doctorate degree in Physiology (Interdisciplinary) from The Pennsylvania State University, Master’s degree in Clinical Exercise Physiology from Northeastern University, and bachelor’s degree in Biology from St. John Fisher College. He completed his Post-doctoral Fellowship at the University of Maryland, School of Medicine in the Division of Gerontology and his Cardiac Rehabilitation internship at Boston University Medical Center. He has received external funding for his research interest from the National Institute of Aging at NIH, the American Federation for Aging Research, and the American College of Sports Medicine.
Mike Pieck, Ph.D.
Small Business Coordinator
National Heart Lung and Blood Institute, NIH
Mike Pieck is the Small Business Coordinator at the National Heart Lung and Blood Institute where he serves as the primary contact for the small business program (SBIR/STTR) and provides oversight and management of the portfolio. He is also involved in developing a suite of support activities for translational research across NHLBI. Prior to joining the NIH, Mike worked in the non-profit sector where he designed and implemented business start-up challenges featuring federally funded and commercially viable inventions. Mike received his PhD in molecular biology from Boston University and completed his postdoctoral training at the USDA’s Emerging Fungal Pathogen Laboratory.
At 2 p.m. we will have 1-on-1 meetings with any of our panelists. If you are interested in scheduling a 1-on-1, email the panelist directly with “Hagerstown Partnering Request” in the subject line. You may also use NIAtranslationalsb@mail.nih.gov as an alternative email for the SBIR team.
- Your name;
- Company name;
- Interest area (licensing, collaboration, SBIR); and
- Whether you have a specific technology in mind
Panelists will schedule meetings on a first come/first serve basis (10 minutes max time). A sign-up sheet will also be available on site, but to ensure a spot advanced scheduling is strongly recommended.